Furthermore, PTEN can promote host immune response against cancer cells by repressing the expression of immunosuppressive cytokines IL-10, IL-6, and VEGF and programmed cell death 1 ligand (PD-L1) in a PI3K/AKT pathway-dependent manner [49, 50]. This evidence concerns the gene AKT1 and cancer.